Agenus to Host Annual Meeting of Stockholders
Get Alerts AGEN Hot Sheet
Join SI Premium – FREE
LEXINGTON, Mass., June 13, 2019 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with a pipeline of immune modulating antibodies, cancer vaccines, adjuvants and adoptive cell therapies1, invites investors and the general public to attend its annual meeting of stockholders on June 19, 2019 at 5:00 p.m. ET. The meeting will be held at the Company's headquarters located at 3 Forbes Road, Lexington, MA 02421. Registration for attendees will start at 4:30 p.m. ET.

Conference Call and Webcast Information:Date: Wednesday, June 19, 2019Time: 5:00 p.m. ETDomestic Dial-in Number: 1-844-492-3727International Dial-in Number: 1-412-317-5118Conference ID: Agenus
Live Webcast: accessible from the Company's website at http://investor.agenusbio.com/presentation-webcasts or with this link https://www.webcaster4.com/Webcast/Page/1556/30853
A replay will be available on the Company's website approximately two hours after the call and will remain available for 90 days.
About AgenusAgenus is a clinical-stage immuno-oncology company focused on the discovery and development of therapies that engage the body's immune system to fight cancer. The Company's vision is to expand the patient populations benefiting from cancer immunotherapy by pursuing combination approaches that leverage a broad repertoire of antibody therapeutics, proprietary cancer vaccine platforms, and adoptive cell therapies (through its AgenTus Therapeutics subsidiary). The Company is equipped with a suite of antibody discovery platforms and a state-of-the-art GMP manufacturing facility with the capacity to support early phase clinical programs. Agenus is headquartered in Lexington, MA. For more information, please visit www.agenusbio.com and our twitter handle @agenus_bio. Information that may be important to investors will be routinely posted on our website and twitter.
Contact:
Agenus Inc. Jennifer Buell, PhD781-674-4420 [email protected]
1Through AgenTus Therapeutics, a subsidiary of Agenus
View original content to download multimedia:http://www.prnewswire.com/news-releases/agenus-to-host-annual-meeting-of-stockholders-300867503.html
SOURCE Agenus Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rise Nano Optics Joins the Vision Council, a Leading Optical Trade Association, Expanding Access to Key Optical Relationship
- cBrain returns to growth and expects more than 15% growth in H2 2026
- Igniting the Spark of Skills! WorldSkills Shanghai 2026 Announced the Second Cohort of Dream Ambassadors
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share